Evidence map›Paper›PMID 37261635›Full record

ArticlePrevention science : the official journal of the Society for Prevention Research2023

Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder.

J D Cance, E T Adams, E J D'Amico, A Palimaru, C S F Fernandes, L E Fiellin, E E Bonar, M A Walton, K A Komro, D Knight and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Prevention science : the official journal of the Society for Prevention Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

J D CanceRTI International, Research Triangle Park, Durham, NC, USA. jcance@rti.org.ORCID 0000-0002-2797-0037
E T AdamsRTI International, Research Triangle Park, Durham, NC, USA.
E J D'AmicoRAND Corporation, Santa Monica, CA, USA.
A PalimaruRAND Corporation, Santa Monica, CA, USA.
C S F FernandesYale University School of Medicine, New Haven, CT, USA.
L E FiellinYale University School of Medicine, New Haven, CT, USA.
E E BonarUniversity of Michigan, Ann Arbor, MI, USA.
M A WaltonUniversity of Michigan, Ann Arbor, MI, USA.
K A KomroRollins School of Public Health, Emory University, Atlanta, USA.
D KnightTexas Christian University, Fort Worth, TX, USA.
K KnightTexas Christian University, Fort Worth, TX, USA.
V RaoMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
S YounMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
L SaavedraRTI International, Research Triangle Park, Durham, NC, USA.
T A RidenourRTI International, Research Triangle Park, Durham, NC, USA.
B DeedsNational Institute on Drug Abuse, MD, Bethesda, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young AdultsU24DA050182 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI GRAHAM, PHILLIP W · 2019 to 2025
$11.6M
Optimized Interventions to Prevent Opioid Use Disorder among Adolescents and Young Adults in the Emergency DepartmentUH3DA050173 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BONAR, ERIN E., WALTON, MAUREEN A · 2020 to 2021
$5.8M
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in CaliforniaUH3DA050235 · NIDA · RAND CORPORATION · PI D'AMICO, ELIZABETH J., DICKERSON, DANIEL LEE · 2020 to 2023
$5.3M
Community Randomized Trial in the Cherokee Nation: CONNECT and CMCA for Preventing Drug Misuse among Older AdolescentsUH3DA050234 · NIDA · EMORY UNIVERSITY · PI KOMRO, KELLI ANN, LIVINGSTON, MELVIN D · 2020 to 2023
$4.9M
Preventing Opioid Use Among Justice-Involved Youth as They Transition to Adulthood: Leveraging Safe Adults (LeSA)UH3DA050250 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, DANICA K · 2020 to 2020
$4.5M
The Role of Family Functioning and Race/Ethnicity on the Efficacy of an Opioid Misuse Prevention Videogame Intervention for AdolescentsUH3DA050251 · NIDA · YALE UNIVERSITY · PI FIELLIN, LYNN ELIZABETH · 2021 to 2021
$4.4M
Does Treating Young Persons Psychopathology Prevent the Onset of Opioid and other Substance Use Disorders?UH3DA050252 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WILENS, TIMOTHY E, YULE, AMY · 2020 to 2020
$3.0M
A digital intervention to prevent the initiation of opioid misuse in adolescents in school-based health centersUG3DA050251 · NIDA · YALE UNIVERSITY · PI FIELLIN, LYNN ELIZABETH · 2019 to 2020
$1.4M
Does Treating Young Persons Psychopathology Prevent the Onset of Opioid and other Substance Use Disorders?UG3DA050252 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WILENS, TIMOTHY E, YULE, AMY · 2019 to 2019
$749k
Optimized Interventions to Prevent Opioid Use Disorder among Adolescents and Young Adults in the Emergency DepartmentUG3DA050173 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BONAR, ERIN E., WALTON, MAUREEN A · 2019 to 2019
$699k
Community Randomized Trial in the Cherokee Nation: CONNECT and CMCA for Preventing Drug Misuse among Older AdolescentsUG3DA050234 · NIDA · EMORY UNIVERSITY · PI KOMRO, KELLI ANN · 2019 to 2019
$676k
NCATS NIH HHS UL1 TR001863NCIPC CDC HHS U01 CE003482NIDA NIH HHS U24 DA050182NIDA NIH HHS UG3 DA050173NIDA NIH HHS UG3 DA050234NIDA NIH HHS UG3 DA050235NIDA NIH HHS UG3 DA050250NIDA NIH HHS UG3 DA050251NIDA NIH HHS UG3 DA050252NIDA NIH HHS UG3/UH3 DA050173NIDA NIH HHS UG3/UH3 DA050234NIDA NIH HHS UG3/UH3 DA050235NIDA NIH HHS UG3/UH3 DA050250NIDA NIH HHS UG3/UH3 DA050251NIDA NIH HHS UG3/UH3 DA050252NIDA NIH HHS UH3 DA050173NIDA NIH HHS UH3 DA050234NIDA NIH HHS UH3 DA050235NIDA NIH HHS UH3 DA050250NIDA NIH HHS UH3 DA050251NIDA NIH HHS UH3 DA050252
6 · The paper itself

Abstract

Substance use disorder prevention programs are most effective when matched appropriately to the baseline risk of the population. Individuals who misuse opioids often have unique risk profiles different from those who use other substances such as alcohol or cannabis. However, most substance use prevention programs are geared toward universal audiences, neglecting key inflection points along the continuum of care. The HEAL Prevention Cooperative (HPC) is a unique cohort of research projects that represents a continuum of care, from community-level universal prevention to indicated prevention among older adolescents and young adults who are currently misusing opioids or other substances. This paper describes the theoretical basis for addressing opioid misuse and opioid use disorder across the prevention continuum, using examples from research projects in the HPC.

Indexed as

CannabisOpioid-Related DisordersPrescription Drug MisuseAdolescentAnalgesics, OpioidContinuity of Patient CareHumansYoung AdultAnalgesics, OpioidBehavioral health continuum of careEvidence-based prevention programsOpioid use disorder

Identifiers

PMID37261635
PMCPMC10689575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.